Evidence browser
Explore the evidence
Loading the evidence…
The Association of Mental Health Providers’ evidence observatory
Evidence browser
Loading the evidence…
Evidence browser
35,847 claims
DEBRA established a drug repurposing platform to accelerate the identification of existing medicines for EB treatment.
2025 saw the establishment of the world’s largest EB drug repurposing platform based here in the UK. This important new partnership made possible with funding from LifeArc will help accelerate the identification of existing medicines that could be safely and effectively used to treat EB.
Operational · Commitment statement · From Debra — annual report and accounts, year ending 31 December 2025, page 17
DEBRA launched a global online EB atlas to enhance understanding of the condition's impacts and improve healthcare strategies.
Our ambition is to create a global online EB atlas. This transformative long-term project aims to enhance understanding of EB and its multifaceted impacts on individuals and society by providing comprehensive, open access information on the epidemiology of EB across the globe.
Service · Commitment statement · From Debra — annual report and accounts, year ending 31 December 2025, page 19
DEBRA renewed strategic partnerships with Fight for Sight, Action Medical Research for Children, and the Medical Research Council to advance EB research.
We were delighted to renew our strategic partnerships with Fight for Sight, Action Medical Research for Children, and the Medical Research Council. These partnerships will support us in advancing EB research and nurturing the next generation of EB researchers.
Commissioning · Policy statement · From Debra — annual report and accounts, year ending 31 December 2025, page 16
DEBRA aims to deepen member engagement and foster a stronger sense of community in 2026.
We remain committed to empowering choice and independence, delivering specialist support, and building a connected, engaged EB community
Service · Policy statement · From Debra — annual report and accounts, year ending 31 December 2025, page 13
DEBRA identified research priorities for each of the four main types of EB through a global partnership study.
We identified the research priorities for EB
Commissioning · Observational claim · From Debra — annual report and accounts, year ending 31 December 2025, page 8
DEBRA secured a significant investment for EB drug repurposing research.
We secured the single largest investment yet, anywhere in the world, into EB drug repurposing research
Commissioning · Observational claim · From Debra — annual report and accounts, year ending 31 December 2025, page 8
DEBRA relies on the support of its members, volunteers, and supporters to achieve its vision.
We cannot make a difference for the EB community on our own. It takes a team effort. Thankfully, we can count on the support of many incredible people who support us on our journey.
Relational · Stakeholder position · From Debra — annual report and accounts, year ending 31 December 2025, page 6
DEBRA aims to improve the quality of life for people with EB through drug repurposing research.
The project will create an innovative clinical trial that will test whether drugs already treating conditions such as psoriasis and eczema, could be used to treat EB too. These treatments have the potential to improve wound healing and quality of life
Research · Policy statement · From Debra — annual report and accounts, year ending 31 December 2025, page 6
DEBRA secured co-funding for a multi-million-pound ART-EB research project in 2025.
Our single biggest highlight of 2025 was our announcement that we had secured co-funding for the new ART-EB research project. The new multi-million-pound project is the single largest investment to date, anywhere in the world, into EB drug repurposing research.
Research · Observational claim · From Debra — annual report and accounts, year ending 31 December 2025, page 6
The charity's website is maintained to ensure the integrity of corporate and financial information.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the Charity’s website.
Operational · Procedural statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 22
The charity's financial statements are prepared in accordance with UK Accounting Standards and the Charities Act 2011.
In preparing these financial statements the Trustees are required to: Select suitable accounting policies and then apply them consistently;
Financial · Procedural statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 22
The charity is mindful of the risks to individuals' privacy and safeguarding needs in its online services.
Many of our services are provided online and the charity needs to remain aware of the risks to individuals’ privacy and the safeguarding needs of an online group.
Operational · Risk statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 20
The charity is reviewing opportunities for joint ventures or collaborative bids with other entities to deliver its charitable objectives more efficiently.
Trustees are now reviewing opportunities to deliver our charitable purpose more efficiently – for example, through joint ventures, collaborative bids with other entities.
Operational · Commitment statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 19
The charity has appointed a fundraising specialist to increase income from grants and other funding opportunities.
We appointed a fundraising specialist to try to increase income from grants and other funding opportunities.
Financial · Commitment statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 19
The charity aims to secure new funding sources, including grants and corporate partnerships.
Securing new sources of funding, including a focus on funding that will support systemic activity addressing healthcare environments as workplaces, is an objective for the Board of Trustees.
Financial · Commitment statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 19
The charity has taken steps to reduce costs, including making two staff redundant and conducting a cost-cutting exercise.
To this end, the Charity has this year made two staff redundant and is conducting a significant cost cutting exercise.
Operational · Procedural statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 19
The charity faces financial sustainability risks due to the shift from emergency funding during COVID-19 to addressing ongoing pressures on healthcare workers.
The current phase of the charity is moving from an emergency context brought about by COVID-19 to addressing the sustained pressures on healthcare workers. This requires us to establish a format and sources of income that meet this need.
Financial · Risk statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 18
Doctors in Distress aims to build up reserves sufficient to cover three months' running costs.
The Trustee’s aim and policy is to build up the reserves sufficient to cover 3 months’ running costs of day-to-day operation.
Governance · Commitment statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 15
Doctors in Distress achieved a surplus of £27,820.82 during the current financial year.
During the current financial year the charity achieved a surplus of £27,820.82 (2025: deficit of £74,928.36) with total reserves at year end to £3,369.29 (2025: £31,190).
Financial · Funding statement · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 15
Doctors in Distress presented evidence on burnout and suicide reduction to the All Party Parliamentary Group for Healthcare workers.
evidence within Parliament on the current working experience of doctors and actions on burnout and suicide reduction
Policy · Stakeholder position · From Doctors in Distress — annual report and accounts, year ending 30 June 2026, page 12